Transaktionen anzeigen
Gesundheitswesen

Empirical Bioscience has been acquired by Fortis Life Sciences

The owner of Empirical Bioscience has sold the company to Fortis Life Sciences.

Empirical Bioscience is a leading developer and manufacturer of enzymes, proteins and reagents for molecular biology and life science applications. Empirical focuses on supplying premium, quality and custom-configured products to the life sciences industry for both research and commercial applications. The company has a comprehensive library of products that can be readily configured to customer specifications and offers technical support to assist with the development and launch of assays and products.

Fortis Life Sciences is a strategic platform providing capital, expertise and operational resources enabling the growth and success of founder-led life science tools companies.

One of Oaklins’ teams in the USA served as the financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences.

DIENSTLEISTUNG
Verkauf
PARTEIEN

Sprechen Sie mit dem Deal Team

 Bradford A. Adams

Bradford A. Adams

Managing Director
Boston, Vereinigte Staaten
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, Vereinigte Staaten
Oaklins TM Capital
 Harrison P. Boeschenstein

Harrison P. Boeschenstein

Analyst
Boston, Vereinigte Staaten
Oaklins TM Capital

Transaktionen

SulAmérica and Rede D’Or São Luiz have announced a combination
Finanzdienstleistungen | Gesundheitswesen

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Mehr erfahren
Dolmen Engineering has been acquired by NIRAS
Bauwirtschaft | Gesundheitswesen

Dolmen Engineering has been acquired by NIRAS

The private shareholders of Dolmen Engineering have sold the company to NIRAS. The integration will enable the two companies to strengthen their positions within the European life science and food & beverage sectors and offer a fully integrated suite of services.

Mehr erfahren
InMedica has acquired J. Pauliuko šeimos klinika
Private Equity | Gesundheitswesen

InMedica has acquired J. Pauliuko šeimos klinika

InMedica, the largest Lithuanian network of medical clinics, has acquired J. Pauliuko šeimos klinika.

Mehr erfahren